Sublingual drug delivery device

Details Sublingual drug delivery device Sublingual drug delivery device

2005-01-18

2010-02-09

Yu, Justine R (Department: 3771)

Surgery

Means for introducing or removing material from body for...

Gas application

C128S203120, C128S203190, C128S200220

Reexamination Certificate

active

07658721

ABSTRACT:
A drug delivery device that aerosolizes a dry powder formulation so that it forms a fine coating in the oral cavity and, more specifically in the sublingual region of the oral cavity is described herein. In the preferred embodiment, the device contains five main parts: (i) a compressed gas canister, (ii) a dispenser body (also referred to herein as the main housing ), (iii) a means for storing one or more doses of a drug formulation, (iv) a means for releasing a dose of the drug formulation such as a gas canister or spring piston and (v) a mouthpiece. Preferred configurations include circular, tubular, and rectangular. The means for storing the drug formulation may be configured to separately store one or more materials. In one embodiment, the means for storing the active agent is in the form of one or more drug discs, where the drug discs contain a plurality of blister packs, each storing one dose of the drug formulation. In another embodiment, the means for storing the active agent is a dosage cartridge containing a single dose of the drug formulation. In yet another embodiment, the drug formulation is stored on a ribbon containing a plurality of blister packs, each storing one dose of the drug formulation.

REFERENCES:
patent: 3921637 (1975-11-01), Bennie et al.
patent: 4196196 (1980-04-01), Tiholiz
patent: 4211769 (1980-07-01), Okada et al.
patent: 5388572 (1995-02-01), Mulhauser et al.
patent: 5474978 (1995-12-01), Bakaysa
patent: 5534488 (1996-07-01), Hoffmann
patent: 5645050 (1997-07-01), Zierenberg et al.
patent: 5650486 (1997-07-01), Felippis
patent: 5653987 (1997-08-01), Modi et al.
patent: 5672359 (1997-09-01), Digenis
patent: 5746227 (1998-05-01), Rose et al.
patent: 5819726 (1998-10-01), Rubsamen et al.
patent: 5849322 (1998-12-01), Ebert et al.
patent: 5888477 (1999-03-01), Gonda
patent: 5898028 (1999-04-01), Jensen
patent: 5929027 (1999-07-01), Takama et al.
patent: 5964417 (1999-10-01), Amann et al.
patent: 6116238 (2000-09-01), Jackson et al.
patent: 6123068 (2000-09-01), Lloyd et al.
patent: 6125844 (2000-10-01), Samiotes
patent: 6264981 (2001-07-01), Zhang
patent: 6310038 (2001-10-01), Havelund
patent: 7192919 (2002-03-01), Tzannis
patent: 6465425 (2002-10-01), Tracy
patent: 6652885 (2003-11-01), Steiner et al.
patent: 6676931 (2004-01-01), Dugger
patent: 6748946 (2004-06-01), Rand et al.
patent: 6941948 (2005-09-01), Staniforth et al.
patent: 6949258 (2005-09-01), Zhang et al.
patent: 6960561 (2005-11-01), Boderke
patent: 7089934 (2006-08-01), Staniforth et al.
patent: 7249687 (2007-07-01), Anderson
patent: 2001/0039260 (2001-11-01), Havelund
patent: 2002/0170560 (2002-11-01), Young et al.
patent: 2002/0198140 (2002-12-01), Havelund
patent: 2003/0015191 (2003-01-01), Armstrong et al.
patent: 2003/0064097 (2003-04-01), Patel et al.
patent: 2003/0172924 (2003-09-01), Staniforth et al.
patent: 2003/0183229 (2003-10-01), Smith et al.
patent: 2004/0216738 (2004-11-01), Edwards et al.
patent: 2005/0005934 (2005-01-01), Harvey
patent: 2005/0016533 (2005-01-01), Schuler et al.
patent: 2005/0150492 (2005-07-01), Dunkley et al.
patent: 2005/0203001 (2005-09-01), Arbit et al.
patent: 2006/0048780 (2006-03-01), Burr et al.
patent: 2006/0067891 (2006-03-01), Modi
patent: 2007/0062525 (2007-03-01), Bonney et al.
patent: 2007/0134279 (2007-06-01), Stern
patent: 2007/0155654 (2007-07-01), Langkjaer
patent: 247684 (1987-07-01), None
patent: 2 069 502 (1981-08-01), None
patent: WO 91/08764 (1991-06-01), None
patent: WO 96/10996 (1996-04-01), None
patent: WO 96/36352 (1996-11-01), None
patent: WO 97/33531 (1997-09-01), None
patent: WO 97/49386 (1997-12-01), None
patent: WO 98/42367 (1998-10-01), None
patent: WO 98/42368 (1998-10-01), None
patent: WO 98/42749 (1998-10-01), None
patent: WO 2004/080401 (2004-09-01), None
patent: WO 2007/047948 (2007-04-01), None
Aungst & Rogers, “Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery”,Pharm. Res., 5(5):305-308 (1988).
Brange, et al., Chemical stability of insulin 1: hydrolytic degradation during storage of pharmaceutical preparations,Pharm. Res., 9:715-726 (1992).
De Sousa, et al., “Biocompatibility of EDTA, EGTA and citric acid”,Braz. Dent. J., 16:3-8 (2005).
Kang, et al., “Subcutaneous insulin absorption explained by insulin's physiochemical properties”,Diabetes Care, 14:942-948 (1991).
Keowmaneechai, et al., “Influence of EDTA and citrate on physiochemical properties of whey protein-stabilized oil-in-water emulsions containing CaCl2”, J. Agricultural and Food, Chemistry, 50:7145-7153 (2002).
Klauser, et al., “Mixtures of human intermediate and human regular insulin in type 1 diabetic patients”,Diabetes Res. and Clin. Practice, 5:185-190 (1988).
Monch & Dehnen, “High-performance liquid chromatography of polypeptides and proteins on a reversed-phase support”,Journal of Chromatography,147:415-418 (1978).
Prabhu, et al., “A study of factors controlling dissolution kinetics of zinc complexed protein suspensions in various ionic species”,Int. J. Pharm., 217(1-2):71-78 (2001).
Quinn, et al., “Minimizing the aggregation of insulin solutions”,J. Pharmaceutical Sci., 72:1472-1473 (1983).
Szepesy & Horvath, “Specific salt effects in hydrophobic interaction chromatography of proteins”,Chromatographia, 26:13-18 (1988).
Todo, et al., “Effect of additives on insulin absorption from intracheally administered dry powders in rats”,Int J. Pharmaceutics, 220:101-110 (2001).

Affiliated with

Also associated with

Rating

Sublingual drug delivery device does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sublingual drug delivery device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sublingual drug delivery device will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4212921